890810 | 18:0 DDAB
Dimethyldioctadecylammonium (Bromide Salt)
18:0 DDAB
Dimethyldioctadecylammonium (Bromide Salt)
Incorporation of the glycolipid trehalose 6,6'-dibehenate (TDB) into cationic liposomes composed of the quaternary ammonium compound dimethyldioctadecylammonium (DDA) produce an adjuvant system which induces a powerful cell-mediated immune response and a strong antibody response, desirable for a high number of disease targets.
CAS Registry Number is a Registered Trademark of the American Chemical Society
DDA
Lou G, Anderluzzi G, Tandrup Schmidt S, Woods S, Gallorini S, Brazzoli M, Giusti F, Ferlenghi I, Johnson R, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection. J Control Release. 2020 Jun 30:S0168-3659(20)30362-X. doi: 10.1016/j.jconrel.2020.06.027. Epub ahead of print. PMID: 32619745.
PubMed ID: 32619745Lee H, Jiang D, Pardridge WM. Lyoprotectant Optimization for the Freeze-Drying of Receptor-Targeted Trojan Horse Liposomes for Plasmid DNA Delivery. Mol Pharm. 2020 Apr 29. doi: 10.1021/acs.molpharmaceut.0c00310. Epub ahead of print. PMID: 32315188.
PubMed ID: 32315188Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2020 Apr;15(4):313-320. doi: 10.1038/s41565-020-0669-6. Epub 2020 Apr 6. PMID: 32251383.
PubMed ID: 32251383Chatzikleanthous D, Schmidt ST, Buffi G, Paciello I, Cunliffe R, Carboni F, Romano MR, O'Hagan DT, D'Oro U, Woods S, Roberts CW, Perrie Y, Adamo R. Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes. J Control Release. 2020 Apr 2:S0168-3659(20)30211-X. doi: 10.1016/j.jconrel.2020.04.001. Epub ahead of print. PMID: 32247804.
PubMed ID: 32247804Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, de Libero G, Williams A, Puzo G, Gilleron M. Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine. 2017 Mar 7;35(10):1395-1402. doi: 10.1016/j.vaccine.2017.01.079. Epub 2017 Feb 9. PMID: 28190740.
PubMed ID: 28190740Derrick SC, Yabe I, Morris S, Cowley S. Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice. Clin Vaccine Immunol. 2016 Jul 5;23(7):638-47. doi: 10.1128/CVI.00232-16. PMID: 27226281; PMCID: PMC4933783.
PubMed ID: 27226281Rose F, Wern JE, Ingvarsson PT, van de Weert M, Andersen P, Follmann F, Foged C. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach. J Control Release. 2015 Jul 28;210:48-57. doi: 10.1016/j.jconrel.2015.05.004. Epub 2015 May 6. PMID: 25957906.
PubMed ID: 25957906Teng X, Tian M, Li J, Tan S, Yuan X, Yu Q, Jing Y, Zhang Z, Yue T, Zhou L, Fan X. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Hum Vaccin Immunother. 2015;11(6):1456-64. doi: 10.1080/21645515.2015.1037057. PMID: 25905680; PMCID: PMC4514263.
PubMed ID: 25905680Gallez A, Palazzo C, Blacher S, Tskitishvili E, Noël A, Foidart JM, Evrard B, Pequeux C, Piel G. Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: An innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α. Int J Pharm. 2020 Jan 5;573:118861. doi: 10.1016/j.ijpharm.2019.118861. Epub 2019 Nov 22.
PubMed ID: 31765774Faria MJ, Machado R, Ribeiro A, Gonçalves H, Real Oliveira MECD, Viseu T, das Neves J, Lúcio M. Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention. Pharmaceutics. 2019 Sep 18;11(9). pii: E485. doi: 10.3390/pharmaceutics11090485.
PubMed ID: 31540519Silva AM, Martins-Gomes C, Fangueiro JF, Andreani T, Souto EB. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines. Pharm Dev Technol. 2019 Sep 11:1-7. doi: 10.1080/10837450.2019.1658774. [Epub ahead of print]
PubMed ID: 31437118Katayama T, Kinugawa S, Takada S, Furihata T, Fukushima A, Yokota T, Anzai T, Hibino M, Harashima H, Yamada Y. A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells. Mitochondrion. 2019 Jul 19;49:66-72. doi: 10.1016/j.mito.2019.07.005. [Epub ahead of print]
PubMed ID: 31326598Yang X, Zhao J, Duan S, Hou X, Li X, Hu Z, Tang Z, Mo F, Lu X. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers. Theranostics. 2019 May 31;9(14):4066-4083. doi: 10.7150/thno.33383. eCollection 2019.
PubMed ID: 31281532Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019 Apr 12;303:91-100. doi: 10.1016/j.jconrel.2019.04.015. [Epub ahead of print]
PubMed ID: 30986436Marcos K. Masukawa, Cintia C. Vequi-Suplicy, Evandro L.Duarte, M. Teresa Lamy. A closer look into laurdan as a probe to monitor cationic DODAB bilayers. Journal of Photochemistry and Photobiology A: Chemistry. 2019 May 1;376:238-246. doi: 10.1016/j.photochem.2019.03.006
Thakur A, Rodríguez-Rodríguez C, Saatchi K, Rose F, Esposito T, Nosrati Z, Andersen P, Christensen D, Häfeli UO, Foged C. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization. Front Immunol. 2018 Nov 30;9:2825. doi: 10.3389/fimmu.2018.02825. eCollection 2018.
PubMed ID: 30555488Oliveira AC, Martens TF, Raemdonck K, Adati RD, Feitosa E, Botelho C, Gomes AC, Braeckmans K, Real Oliveira ME. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing. ACS Appl Mater Interfaces. 2014 May 14;6(9):6977-89. doi: 10.1021/am500793y. Epub 2014 Apr 18.
PubMed ID: 24712543Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 1993 Jul 9;261(5118):209-11.
PubMed ID: 7687073Bicelles can be integrated into standard crystallization protocols, and in contrast to micelles, bicelles maintain the protein in a more native bilayer environment allowing proteins to be captured in a more biologically relevant orientation. Reference/Protocol
- Certificate of Analysis (Lot No. 890810C-200MG-A-029 and 6353CNA029)
- Certificate of Analysis (Lot No. 890810C-25MG-A-029 and 6353CJA029)
- Certificate of Analysis (Lot No. 890810P-1G-A-029 and 6353PQA029)
- Certificate of Analysis (Lot No. 890810P-200MG-A-029 and 6353PNA029)
- Certificate of Analysis (Lot No. 890810P-25MG-A-029 and 6353PJA029)
- Certificate of Analysis (Lot No. 890810P-500MG-A-029 and 6353PPA029)
- Certificate of Analysis (Lot No. 890810P-1G-B-029 and 6353PQB029)
- Certificate of Analysis (Lot No. 890810P-25MG-B-029 and 6353PJB029)
- Certificate of Analysis (Lot No. 890810P-200MG-B-029 and 6353PNB029)
- Certificate of Analysis (Lot No. 890810P-1G-C-029 and 6353PQC029)
- Certificate of Analysis (Lot No. 890810C-25MG-B-029 and 6353CJB029)
- Certificate of Analysis (Lot No. 890810P-1G-D-029 and 6353PQD029)
- Certificate of Analysis (Lot No. 890810P-200MG-C-029 and 6353PNC029)
- Certificate of Analysis (Lot No. 890810P-200MG-D-029 and 6353PND029)
- Certificate of Analysis (Lot No. 890810P-200MG-E-029 and 6353PNE029)
- Certificate of Analysis (Lot No. 890810P-1G-E-029 and 6353PQE029)
- Certificate of Analysis (Lot No. 890810P-200MG-A-030 and 6353PNA030)
- Certificate of Analysis (Lot No. 890810C-25MG-A-030 and 6353CJA030)
- Certificate of Analysis (Lot No. 890810C-200MG-A-030 and 6353CNA030)
- Certificate of Analysis (Lot No. 890810P-200MG-B-030 and 6353PNB030)
- Certificate of Analysis (Lot No. 890810P-25MG-C-030 and 6353PJC030)
- Certificate of Analysis (Lot No. 890810P-1G-B-030 and 6353PQB030)
- Certificate of Analysis (Lot No. 890810P-25MG-D-030 and 6353PJD030)
- Certificate of Analysis (Lot No. 890810C-200MG-B-030 and 6353CNB030)
- Certificate of Analysis (Lot No. 890810C-200MG-A-031 and 6353CNA031)
- Certificate of Analysis (Lot No. 890810P-25MG-A-031 and 6353PJA031)
- Certificate of Analysis (Lot No. 890810P-1G-A-031 and 6353PQA031)
- Certificate of Analysis (Lot No. 890810P-1G-C-030 and 6353PQC030)
- Certificate of Analysis (Lot No. 890810P-25MG-E-030 and 6353PJE030)
- Certificate of Analysis (Lot No. 890810P-200MG-C-030 and 6353PNC030)
- Certificate of Analysis (Lot No. 890810P-25MG-B-031 and 6353PJB031)
- Certificate of Analysis (Lot No. 890810P-200MG-A-031 and 6353PNA031)
- Certificate of Analysis (Lot No. 890810C-25MG-A-031 and 6353CJA031)
- Certificate of Analysis (Lot No. 890810P-200MG-B-031 and 6353PNB031)